Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples

Prenatal Diagnosis

Volumn 33, Issue 6, 2013, Pages 569-574

  Futch, Tracy ^a   Spinosa, John ^a,b   Bhatt, Sucheta ^a   de Feo, Eileen ^a   Rava, Richard P ^a   Sehnert, Amy J ^a  

^a Verinata Health Inc   (United States)

^b SCRIPPS MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANEUPLOIDY; ARTICLE; BLOOD SAMPLING; CHROMOSOME 13; CHROMOSOME 18; CHROMOSOME 21; CLINICAL LABORATORY; CONTROLLED STUDY; CYSTIC LYMPHANGIOMA; CYTOGENETICS; DNA DETERMINATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MATERNAL PLASMA; MONOSOMY X; NONINVASIVE PRENATAL TESTING; OUTCOME ASSESSMENT; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; TRISOMY 18; TRISOMY 21;

ADOLESCENT; ADULT; ANEUPLOIDY; DNA; EFFICIENCY, ORGANIZATIONAL; FEMALE; FETUS; GENETIC TESTING; HUMANS; LABORATORIES, HOSPITAL; MIDDLE AGED; MOTHERS; PREGNANCY; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84878120833     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4123     Document Type: Article

References (16)

1. Bianchi DW, Platt LD, Goldberg JD, et al. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012;119:890-901.
2. Palomaki GE, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011;13:913-20.
3. Norton ME, Brar H, Weiss J, et al. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;207:137.e1-8.
4. Benn P, Borrell A, Cuckle H, et al. Prenatal Detection of Down Syndrome using Massively Parallel Sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011. Prenat Diagn 2012;32:1-2.
5. Devers PL, Cronister A, Ormond KE, et al. Noninvasive prenatal testing/noninvasive prenatal diagnosis: the position of the National Society of Genetic Counselors (by NSGC Public Policy Committee). NSGC Position Statements 2012.
6. American College of Obstetricians and Gynecologists Committee on Genetics. Committee Opinion No. 545: noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol 2012;120:1532-4.
7. Bianchi DW, Prosen T, Platt LD, et al. Massively parallel sequencing of maternal plasma DNA in 113 cases of fetal nuchal cystic hygroma. Obstet Gynecol 2013, DOI: 10.1097/AOG.0b013e31828ba3d8
8. Osborne CM, Hardisty E, Devers P, et al. Discordant noninvasive prenatal testing results in a patient subsequently diagnosed with metastatic disease. Prenat Diagn 2013;33:609-11.
9. Schubert R, Eggermann T, Hofstaetter C, et al. Clinical, cytogenetic, and molecular findings in 45, X/47, XX, +18 mosaicism: clinical report and review of the literature. Am J Med Genet 2002;110:278-82.
10. Jaruratanasirikul S, Jinorose U. An infant with Down-Turner double aneuploidy: a case report and literature review. J Med Assoc Thai = Chotmaihet thangphaet 1995;78:108-12.
11. Nagaishi M, Yamamoto T, Iinuma K, et al. Chromosome abnormalities identified in 347 spontaneous abortions collected in Japan. J Obstet Gynaecol Res 2004;30:237-41.
12. Palomaki GE, Deciu C, Kloza EM, et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med 2012;14:296-305.
13. Dan S, Wang W, Ren J, et al. Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11, 105 pregnancies with mixed risk factors. Prenat Diagn 2012;32:1225-32.
14. ACOG Committee on Practice Bulletin. ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol 2007;109:217-27.
15. Norton ME, Rose NC, Benn P. Noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol 2013;121:847-50.
16. Rose NC, Lagrave D, Hafen B, et al. The impact of utilization of early aneuploidy screening on amniocenteses available for training in obstetrics and fetal medicine. Prenat Diagn 2013;33:242-4.